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Background
3,4-Methylenedioxymethamphetamine (MDMA or
‘ecstasy’) tablets are frequently contaminated by 4-MTA
(‘flatliner’), an amphetamine derivative which is known
to induce severe human intoxication and even death.
Although an equipotent inducer of SERT-dependent
5-HT release in vivo, 4-MTA does not induce MDMA-
like serotoninergic neurotoxicity in rats. Instead, 4-MTA
users typically report unpleasant sympathomimetic
effects such as tachycardia, tremors, stomach cramps,
headache and sweating following ingestion. Here, for the
first time we investigate the cytotoxic potency of
4-MTA in a catecholaminergic system.
Methods
SH-SY5Y cells express both dopamine and noradrena-
line transporters (DAT, NET) in the presence of vesicu-
lar monoamine transporter 2 (VMAT2) and were
therefore chosen as the ideal catecholaminergic model
in which to examine the molecular mechanisms of
4-MTA and MDMA-induced cytotoxicity in vitro.C e l l
viability was determined using the MTT assay and vali-
dated using flow cytometry via PI exclusion. ROS pro-
duction, mitochondrial membrane potential (MMP),
apoptosis and the cell cycle were examined via flow
cytometry using DCFH2DA, JC-1, annexin V/PI and PI
respectively. The level of intracellular calcium was deter-
mined ratiometrically by confocal microscopy using two
visible wavelength Ca
2+-sensitive dyes, Fluo-3 and Fura
Red.
Results
4-MTA was significantly more cytotoxic than MDMA at
24 h, demonstrating an EC50 of 0.60 mM in contrast to
2.01 mM for MDMA. In addition, the combination of
MDMA and 4-MTA at low concentrations significantly
increased cytotoxicity compared to that of each drug
alone. 4-MTA-induced cell death was reduced by the
anti-oxidant N-acetyl-L-cysteine (NAC) but not by the
non-selective monoamine transport inhibitor indatraline,
indicating that monoamine transport is not a require-
ment of 4-MTA-induced cytotoxicity. Drug-induced cell
death was pre-empted by rapid intracellular Ca
2+ influx,
mitochondrial membrane depolarization (MMD), ROS
production and caspase 9 activation. MDMA and
4-MTA also induced phosphatidlyserine exposure and
caspase-dependent DNA fragmentation at 24 h indica-
tive of cell death via apoptosis.
Conclusions
Although both MDMA and 4-MTA induced apoptosis
via the mitochondrial death pathway, 4-MTA does so at
more physiologically relevant concentrations and may
therefore be a potent synergistic adjunct when mixed
with MDMA.
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